STIFEL FINANCIAL CORP - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 100 filers reported holding ATHIRA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q2 2023$73,162
-12.9%
24,800
-26.2%
0.00%
Q1 2023$83,966
-22.2%
33,586
-1.3%
0.00%
Q4 2022$107,861
+259.5%
34,025
+233.6%
0.00%
Q3 2022$30,000
-96.5%
10,200
-59.8%
0.00%
-100.0%
Q4 2020$869,00025,3810.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 1,196,196$11,220,0001.44%
Logos Global Management LP 1,855,812$17,408,0001.26%
ACUTA CAPITAL PARTNERS, LLC 297,362$2,789,0000.98%
Bristlecone Advisors, LLC 761,563$7,143,0000.94%
SILVERARC CAPITAL MANAGEMENT, LLC 106,388$998,0000.56%
Perceptive Advisors 3,425,916$32,135,0000.47%
DAFNA Capital Management LLC 160,983$1,510,0000.40%
PATHSTONE FAMILY OFFICE, LLC 1,146,447$10,754,0000.31%
RTW INVESTMENTS, LP 1,906,557$17,884,0000.27%
EMC Capital Management 26,487$346,0000.19%
View complete list of ATHIRA PHARMA INC shareholders